Engineers Gate Manager’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-5,040
Closed -$771K 2206
2021
Q1
$771K Buy
5,040
+3,340
+196% +$517K 0.04% 712
2020
Q4
$266K Sell
1,700
-3,794
-69% -$488K 0.01% 1371
2020
Q3
$629K Sell
5,494
-6,289
-53% -$678K 0.03% 860
2020
Q2
$1.32M Buy
11,783
+4,754
+68% +$505K 0.07% 466
2020
Q1
$631K Sell
7,029
-7,703
-52% -$756K 0.05% 652
2019
Q4
$1.59M Sell
14,732
-22,541
-60% -$2.41M 0.07% 439
2019
Q3
$3.65M Buy
37,273
+30,082
+418% +$3.39M 0.19% 151
2019
Q2
$941K Buy
+7,191
New +$927K 0.05% 522
2016
Q3
Sell
-26,600
Closed -$3.11M 810
2016
Q2
$3.11M Buy
+26,600
New +$3.77M 0.22% 154
2015
Q4
Sell
-1,600
Closed -$250K 841
2015
Q3
$250K Buy
+1,600
New +$292K 0.02% 553
2015
Q2
Sell
-4,106
Closed -$712K 1227
2015
Q1
$712K Buy
+4,106
New +$743K 0.09% 396

Other funds holding ALXN